Earth Science Tech, Inc. (ETST) Stock Analysis

Earth Science Tech, Inc. (ETST) Healthcare & Pipeline Overview

Earth Science Tech, Inc. operates as a biotechnology firm focused on developing and distributing nutraceuticals, bioceuticals, and dietary supplements globally. The company addresses diverse health and wellness needs, offering a wide array of products and delivery forms, alongside medical equipment, through a multi-channel distribution strategy.

What Is the Investment Thesis for ETST?

Earth Science Tech, Inc. (ETST) operates in the growing global nutraceutical and dietary supplement market, demonstrating a focused approach to health and wellness solutions. The company's diverse product portfolio, encompassing hemp oils, vitamins, and botanicals, alongside a multi-channel distribution strategy including online sales, positions it to capture market share. Financially, ETST reports a Gross Margin of 65.1%, indicating strong cost management relative to revenue, and a Profit Margin of 10.0%, reflecting profitability. With a market capitalization of $25.9M and a P/E ratio of 6.77, the company presents as a small-cap entity with potential for growth, albeit with a Beta of 2.37 suggesting higher volatility. Key growth catalysts include the expansion of its medical equipment segment, increased penetration of its online sales channels, and the introduction of new formulations addressing specific health conditions. The company's ability to navigate regulatory landscapes pertinent to supplements and medical devices will be crucial for sustained expansion.

Based on FMP financials and quantitative analysis

ETST Key Highlights

Earth Science Tech, Inc. maintains a robust Gross Margin of 65.1%, significantly higher than many industry averages, indicating efficient production or strong pricing power for its nutraceutical and supplement products.

• The company reported a Profit Margin of 10.0%, demonstrating its ability to translate revenues into net income within the competitive healthcare and supplement sectors.
• With a Market Capitalization of $25.9M, ETST is positioned as a micro-cap company, suggesting potential for significant growth but also implying higher investment risk and liquidity considerations.
• ETST's Price-to-Earnings (P/E) ratio stands at 15.04, providing a valuation metric relative to its earnings, which can be compared against industry peers.
• The company exhibits a Beta of 2.37, indicating that its stock price tends to be more volatile than the overall market, which is a common characteristic for smaller companies in emerging or specialized segments of the healthcare industry.

Who Are ETST's Competitors?

ETST is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are ETST's Key Strengths?

Diverse product portfolio covering a wide range of health and wellness needs, including hemp oils and traditional supplements.

• Strong gross margin of 65.1% indicates efficient cost management or premium product pricing.
• Multi-channel distribution strategy, including online sales, retail stores, clinics, and pharmacies, ensures broad market access.
• Offers products in various formulations and delivery forms, catering to diverse consumer preferences.
• Presence in the medical equipment and devices segment provides diversification beyond supplements.

What Are ETST's Weaknesses?

Small market capitalization of $25.9M suggests limited financial resources compared to larger competitors and potential for higher stock volatility.

• Beta of 2.37 indicates significant stock price volatility, which may deter risk-averse investors.
• Operating on the OTC market, specifically 'OTC Other,' implies lower transparency and potentially reduced investor confidence.
• Reliance on the highly competitive and often scrutinized nutraceutical and dietary supplement market.
• Disclosure status on the OTC market is 'Unknown,' which can raise concerns about financial transparency.

What Could Drive ETST Stock Higher?

ETST catalyst: Introduction of new, scientifically-backed nutraceutical formulations targeting specific health conditions, potentially expanding market reach and consumer appeal.

• Expansion into new international markets for its hemp-derived products, capitalizing on evolving global regulatory frameworks and increasing consumer demand.
• Growth in online sales channels, driven by enhanced digital marketing efforts and improved e-commerce platform functionality, contributing to higher direct-to-consumer revenue.
• Strategic partnerships with larger distributors or healthcare providers to expand the reach of its medical equipment and devices segment.
• Favorable shifts in regulatory policies regarding the sale and marketing of dietary supplements and hemp-derived products, potentially reducing operational hurdles.

What Are the Key Risks for ETST?

Intense competition within the highly fragmented nutraceutical and dietary supplement market, leading to pricing pressures and challenges in market share growth.

• Regulatory scrutiny and potential changes in regulations for health claims, manufacturing practices, and labeling of supplements, which could impact product marketability and compliance costs.
• Challenges in maintaining product efficacy and quality control across its diverse product portfolio, risking reputational damage and consumer trust.
• Limited liquidity and high volatility associated with trading on the 'OTC Other' market, potentially impacting investor confidence and capital raising efforts.
• Dependence on third-party suppliers for raw materials, particularly for specialized ingredients like hemp, exposing the company to supply chain disruptions and cost fluctuations.

What Are the Growth Opportunities for ETST?

• **Expansion of Hemp-Derived Product Portfolio**: The market for hemp-derived products, particularly CBD oils, is experiencing significant growth due to increasing consumer acceptance and evolving regulatory frameworks. Earth Science Tech, Inc. can capitalize on this by introducing new, innovative hemp oil formulations and delivery methods, targeting specific conditions like advanced pain management or cognitive support. The global CBD market is projected to reach substantial valuations, offering a clear runway for ETST to expand its existing offerings and capture a larger share of this high-growth segment over the next 3-5 years, leveraging its current expertise and brand recognition in this area.
• **Enhanced E-commerce and Direct-to-Consumer (DTC) Strategy**: With a significant portion of supplement sales shifting online, strengthening its e-commerce platform and DTC channels presents a substantial growth opportunity for ETST. By investing in digital marketing, optimizing user experience, and expanding its online product range, the company can reach a broader global audience more efficiently. This strategy allows for higher margins compared to traditional retail, direct engagement with customers, and rapid adaptation to market feedback. This digital-first approach could drive significant revenue growth over the next 2-4 years, expanding beyond its current retail and pharmacy footprint.
• **Geographic Market Penetration in Emerging Economies**: While ETST states a 'worldwide' focus, specific strategic expansion into high-growth emerging markets in Asia, Latin America, or Eastern Europe could unlock new revenue streams. These regions often present large, underserved populations with growing disposable incomes and increasing awareness of health and wellness products. Tailoring product offerings to local preferences and navigating regional regulatory requirements would be key. This long-term growth opportunity, spanning 5-10 years, could significantly diversify ETST's revenue base and reduce reliance on established markets.
• **Diversification into Specialized Medical Equipment and Devices**: Earth Science Tech, Inc. already provides medical equipment and devices, a segment that offers higher barriers to entry and potentially more stable revenue streams compared to the competitive supplement market. Expanding this segment by focusing on niche diagnostic tools, therapeutic devices, or home healthcare equipment that complements its existing health focus could be a strategic move. This diversification could leverage existing relationships with clinics and pharmacies, creating cross-selling opportunities and enhancing its overall healthcare value proposition over the next 3-7 years.
• **Strategic Partnerships and Acquisitions for Product Innovation**: Forming strategic alliances with research institutions, ingredient suppliers, or smaller innovative biotech companies could accelerate ETST's product development pipeline and market reach. Acquisitions of companies with complementary product lines or advanced R&D capabilities could rapidly expand its intellectual property and market presence in specific therapeutic areas. This strategy would allow ETST to quickly introduce novel bioceuticals or proprietary formulations, staying ahead of market trends and competitive pressures, with potential impacts visible within 1-3 years post-deal execution.

What Threats Does ETST Face?

• Intense competition from established pharmaceutical companies and numerous smaller players in the supplement market.
• Evolving and potentially stricter regulatory scrutiny on product claims, manufacturing, and marketing of nutraceuticals and dietary supplements.
• Risk of product efficacy challenges or negative publicity, which could damage brand reputation and consumer trust.
• Supply chain disruptions or increased raw material costs, particularly for specialized ingredients like hemp.
• Economic downturns impacting consumer discretionary spending on health and wellness products.

What Are ETST's Competitive Advantages?

• **Diverse Product Portfolio**: Offers a wide array of nutraceuticals, bioceuticals, and dietary supplements, including hemp oils, vitamins, and botanicals, catering to a broad spectrum of health concerns.
• **Multiple Delivery Forms**: Provides products in various formulations like capsules, liquids, creams, and sprays, enhancing consumer choice and accessibility.
• **Multi-Channel Distribution**: Utilizes a comprehensive distribution network encompassing retail stores, clinics, pharmacies, and a robust online presence, ensuring wide market reach.
• **Global Reach**: Markets its products worldwide, suggesting an established infrastructure for international sales and distribution.
• **Vertical Integration (Partial)**: The provision of medical equipment and devices alongside supplements creates potential for cross-selling and a broader healthcare offering.

What Does ETST Do?

Earth Science Tech, Inc. (ETST) is a biotechnology company established in 2010, initially incorporated as Ultimate Novelty Sports, Inc. The company underwent a strategic transformation, rebranding to Earth Science Tech, Inc. in March 2014, to better reflect its evolving focus on health and wellness. Headquartered in Doral, Florida, ETST has since positioned itself as a provider of nutraceuticals, bioceuticals, and dietary supplements, catering to a global market. Its core mission revolves around delivering nutritional and dietary solutions aimed at addressing a broad spectrum of health concerns, including chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea, aging, and general wellness. The company's extensive product portfolio encompasses a variety of offerings such as hemp oils, vitamins, minerals, herbs, botanicals, personal care products, homeopathies, and functional foods. These products are available in numerous formulations and delivery forms, including capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders, and whole herbs, providing consumers with diverse options to suit their preferences and needs. ETST employs a comprehensive distribution model, reaching its customer base through its own retail stores, affiliated clinics, pharmacies, and a robust online presence. Beyond its supplement offerings, Earth Science Tech, Inc. has also diversified into the provision of medical equipment and devices, further solidifying its presence within the broader healthcare sector and expanding its revenue streams. With 32 employees, the company maintains its operational base in Miami, US, continuing to innovate within the specialty and generic drug manufacturing industry.

What Products and Services Does ETST Offer?

• Develops and distributes nutraceuticals, bioceuticals, and dietary supplements.
• Offers products for chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea, aging, and overall wellness.
• Sells a wide range of products including hemp oils, vitamins, minerals, herbs, botanicals, personal care items, homeopathies, and functional foods.
• Provides products in various forms: capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders, and whole herbs.
• Distributes products through its own retail stores, clinics, pharmacies, and online channels globally.
• Supplies medical equipment and devices to complement its health and wellness offerings.

How Does ETST Make Money?

• Generates revenue through the direct sale of nutraceuticals, bioceuticals, and dietary supplements to consumers.
• Utilizes a multi-channel distribution strategy, including proprietary retail stores, clinics, and pharmacies, to reach diverse customer segments.
• Leverages an online sales platform to facilitate direct-to-consumer purchases, expanding its global market reach and potentially improving margin capture.
• Derives revenue from the sale of medical equipment and devices, diversifying its income streams within the healthcare sector.

What Industry Does ETST Operate In?

Earth Science Tech, Inc. operates within the 'Drug Manufacturers - Specialty & Generic' industry, specifically targeting the burgeoning nutraceuticals, bioceuticals, and dietary supplements market. This segment is characterized by increasing consumer demand for preventative health solutions, natural remedies, and personalized nutrition. The global dietary supplements market, for instance, is projected to continue its growth trajectory, driven by an aging population, rising health consciousness, and a greater emphasis on wellness. ETST's focus on a wide array of products, from hemp oils to vitamins and botanicals, positions it to capitalize on these trends. The competitive landscape is fragmented, comprising large pharmaceutical companies with dedicated supplement divisions, specialized nutraceutical firms, and numerous smaller players. ETST differentiates itself through its diverse product forms and multi-channel distribution, including online sales, which is crucial in a market increasingly influenced by e-commerce.

Who Are ETST's Key Customers?

• Individuals seeking solutions for chronic pain, joint pain, and inflammation.
• Consumers looking for support with conditions like seizures, high blood pressure, memory loss, and depression.
• Individuals focused on weight management, nausea relief, anti-aging, and general overall wellness.
• Customers interested in natural and alternative medicine options, including hemp oils and botanical supplements.
• Clinics and pharmacies that stock and distribute health and wellness products and medical devices.

Company Profile

Earth Science Tech, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Miami, US. The company is led by CEO Giorgio R. Saumat. ETST has traded publicly since 2014.

Return on equity for Earth Science Tech, Inc. stands at 66.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 40.5%, showing how much profit it generates from its asset base. ETST trades at a trailing price-to-earnings ratio of 6.77, below the Healthcare sector average of ~21.50x. Its free cash flow yield is 2.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.93 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 7.3%, the inverse of the P/E and a quick read on earnings relative to price.

ETST Valuation & Market Position

With a $25.9M market cap, Earth Science Tech, Inc. sits in the micro-cap segment of the market.

Quarterly Financial Performance: Earth Science Tech, Inc.

Revenue for Earth Science Tech, Inc. came in at $9.0M during Q1 FY2026, a 5.0% contraction versus the preceding quarter. The company recorded net income of $724K, with diluted EPS of $0.00. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Healthcare. Across the four most recent quarters, ETST averaged $0.00 in diluted EPS.

Earth Science Tech, Inc.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 7.30 places it in the safe zone, indicating low near-term bankruptcy risk.

Wall Street analysts project Earth Science Tech, Inc. revenue of about $42.0M for fiscal 2027, with EPS near $0.01.

The most recent 12 insider filings for Earth Science Tech, Inc. break down as 0 sales and 12 purchases. On net that is roughly 515K shares acquired (about $89K) — insiders putting money in tends to read as conviction.

ETST Financials

ETST Latest News

ETST Analyst Consensus

ETST MoonshotScore

Common Questions About ETST (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources